| RS2520533109 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520533213 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520533445 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520534125 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520534155 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520537460 |
BRWD3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2520538578 |
NXT2
|
Health Risk |
Likely pathogenic |
Male infertility, Male infertility |
| RS2520540378 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, Thyroid cancer |
| RS2520540499 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520540555 |
PHF6
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2520541219 |
PHF6
|
Health Risk |
Pathogenic |
Borjeson-Forssman-Lehmann syndrome, Borjeson-Forssman-Lehmann syndrome |
| RS2520543281 |
PHF6
|
Health Risk |
Likely pathogenic |
Borjeson-Forssman-Lehmann syndrome, Borjeson-Forssman-Lehmann syndrome |
| RS2520543380 |
PHF6
|
Health Risk |
Pathogenic |
Borjeson-Forssman-Lehmann syndrome, Borjeson-Forssman-Lehmann syndrome |
| RS2520543421 |
PHF6
|
Health Risk |
Likely pathogenic |
— |
| RS2520543764 |
PHF6
|
Health Risk |
Pathogenic |
Borjeson-Forssman-Lehmann syndrome, Nonpapillary renal cell carcinoma |
| RS2520551116 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2520551638 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520551746 |
BTK
|
Health Risk |
Likely pathogenic |
— |
| RS2520551846 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520553985 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520558559 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520558980 |
BRWD3
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 93 |
| RS2520563603 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2520564210 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520564761 |
BTK
|
Health Risk |
Likely pathogenic |
— |
| RS2520567227 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2520570662 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520571628 |
BTK
|
Health Risk |
Likely pathogenic |
BTK-related disorder, BTK-related disorder |
| RS2520573356 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, Thyroid cancer |
| RS2520573512 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520573534 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520573659 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520574221 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2520574237 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520578180 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2520579087 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520581934 |
STEEP1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 107 |
| RS2520588778 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2520589572 |
BTK
|
Health Risk |
Pathogenic |
— |
| RS2520589915 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520590361 |
SYP
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 96 |
| RS2520596891 |
IQSEC2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2520597428 |
TAF1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked |
| RS2520605467 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520610529 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520610891 |
BTK
|
Health Risk |
Pathogenic |
— |
| RS2520611258 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2520611305 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520611413 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520611436 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520611496 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2520620698 |
UBE2A
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Nascimento type, Nonpapillary renal cell carcinoma |
| RS2520635065 |
DOCK11
|
Health Risk |
Pathogenic |
Autoinflammatory disease, multisystem |
| RS2520644434 |
PHF6
|
Health Risk |
Pathogenic |
Borjeson-Forssman-Lehmann syndrome, Borjeson-Forssman-Lehmann syndrome |
| RS2520644535 |
PHF6
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2520644840 |
PHF6
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2520646399 |
DCAF12L1
|
Health Risk |
Likely pathogenic |
Male infertility with azoospermia or oligozoospermia due to single gene mutation, Male infertility with azoospermia or oligozoospermia due to single gene mutation |
| RS2520655535 |
UBE2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2520655936 |
UBE2A
|
Health Risk |
Pathogenic |
— |
| RS2520655961 |
UBE2A
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Nascimento type, Syndromic X-linked intellectual disability Nascimento type |
| RS2520656988 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520657043 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2520657374 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520659812 |
UBE2A
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Nascimento type, Syndromic X-linked intellectual disability Nascimento type |
| RS2520668139 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520668256 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2520668390 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520668410 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2520674759 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2520676263 |
PHF6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2520676862 |
TAF1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked |
| RS2520692544 |
GRIA3
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability 94, Syndromic X-linked intellectual disability 94 |
| RS2520693959 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520694308 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2520695220 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2520695634 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2520696464 |
FRMD7
|
Health Risk |
Pathogenic |
— |
| RS2520696502 |
FRMD7
|
Health Risk |
Pathogenic |
— |
| RS2520699165 |
FRMD7
|
Health Risk |
Pathogenic |
— |
| RS2520702216 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2520704437 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS2520715667 |
RBM10
|
Health Risk |
Pathogenic |
TARP syndrome, TARP syndrome |
| RS2520722271 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2520722295 |
PCDH19
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS2520731322 |
FRMD7
|
Health Risk |
Likely pathogenic |
Nystagmus 1, congenital |
| RS2520742477 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Congenital stationary night blindness 2A, Congenital stationary night blindness 2A |
| RS2520742671 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS2520744315 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS2520747479 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS2520748309 |
MT-CYB
|
Health Risk |
Likely pathogenic |
MELAS syndrome, MELAS syndrome |
| RS2520754068 |
IDS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-II |
| RS2520754446 |
IDS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-II |
| RS2520754488 |
FRMD7
|
Health Risk |
Pathogenic |
— |
| RS2520754627 |
FRMD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Nystagmus 1, congenital |
| RS2520754861 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520754916 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520755303 |
FRMD7
|
Health Risk |
Pathogenic |
— |
| RS2520756362 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520756537 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520757198 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |